Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer

Breast Cancer Research and Treatment

Volumn 129, Issue 3, 2011, Pages 887-899

  Madeleine, Margaret M ^a,b   Johnson, Lisa G ^a   Malkki, Mari ^a   Resler, Alexa J ^a,b   Petersdorf, Effie W ^a   McKnight, Barbara ^a,b   Malone, Kathleen E ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast cancer; Genetic variation; IL6; Proinflammatory cytokine genes; TNF

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; CYSTEINE; ESTROGEN RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PROGESTERONE; PROLINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CONTROLLED STUDY; DNA FLANKING REGION; FAMILY HISTORY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HISTOPATHOLOGY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MENOPAUSE; PARITY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTORS;

EID: 80052565763     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1520-4     Document Type: Article

References (40)

1. EF Adams B Rafferty MC White 1991 Interleukin 6 is secreted by breast fibroblasts and stimulates 17 beta-oestradiol oxidoreductase activity of MCF-7 cells: possible paracrine regulation of breast 17 beta-oestradiol levels Int J Cancer 49 118 121 1874565 10.1002/ijc.2910490122 1:CAS:528:DyaK3MXmtVCktrw%3D
2. M Allinen R Beroukhim L Cai C Brennan J Lahti-Domenici H Huang D Porter M Hu L Chin A Richardson S Schnitt WR Sellers K Polyak 2004 Molecular characterization of the tumor microenvironment in breast cancer Cancer Cell 6 17 32 15261139 10.1016/j.ccr.2004.06.010 1:CAS:528:DC%2BD2cXmtlKnt7o%3D (Pubitemid 38903159)
3. IA Azmy SP Balasubramanian AG Wilson TJ Stephenson A Cox NJ Brown MW Reed 2004 Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity Breast Cancer Res 6 395 400 10.1186/bcr802
4. CS Carlson MA Eberle MJ Rieder Q Yi L Kruglyak DA Nickerson 2004 Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium Am J Hum Genet 74 106 120 14681826 10.1086/381000 1:CAS:528:DC%2BD2cXlvVOrsA%3D%3D (Pubitemid 38085242)
5. LM Coussens Z Werb 2001 Inflammatory cells and cancer: think different! J Exp Med 193 F23 F26 11257144 10.1084/jem.193.6.F23 1:CAS:528: DC%2BD3MXitFKhs7k%3D
6. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 12490959 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D (Pubitemid 36019639)
7. MM de Jong IM Nolte EG de Vries M Schaapveld JH Kleibeuker E Oosterom JC Oosterwijk AH van der Hout G van der Steege M Bruinenberg HM Boezen GJ te Meerman WT van der Graaf 2003 The HLA class III subregion is responsible for an increased breast cancer risk Hum Mol Genet 12 2311 2319 12915440 10.1093/hmg/ddg245 (Pubitemid 37160875)
8. MT Dorak W Shao HK Machulla ES Lobashevsky J Tang MH Park RA Kaslow 2006 Conserved extended haplotypes of the major histocompatibility complex: further characterization Genes Immun 7 450 467 16791278 10.1038/sj.gene.6364315 1:CAS:528:DC%2BD28XptFWisb4%3D (Pubitemid 44323679)
9. S Dudoit JP Shaffer JC Boldrick 2003 Multiple hypothesis testing in microarray experiments Stat Sci 18 71 103 10.1214/ss/1056397487 (Pubitemid 41461823)
10. LJ Duncan NG Coldham MJ Reed 1994 The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells J Steroid Biochem Mol Biol 49 63 68 8003440 10.1016/0960-0760(94)90301-8 1:CAS:528:DyaK2cXkt1Ohtrc%3D (Pubitemid 24219210)
11. GC Fanning M Bunce CM Black KI Welsh 1997 Polymerase chain reaction haplotyping using 3' mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha Tissue Antigens 50 23 31 9243751 10.1111/j.1399-0039.1997.tb02829.x 1:CAS:528:DyaK2sXltVekuro%3D (Pubitemid 27273708)
12. L Ferrucci G Izmirlian S Leveille CL Phillips MC Corti DB Brock JM Guralnik 1999 Smoking, physical activity, and active life expectancy Am J Epidemiol 149 645 653 10192312 1:STN:280:DyaK1M3gs1Ggsg%3D%3D (Pubitemid 29162714)
13. DM Friedrichsen KE Malone DR Doody JR Daling EA Ostrander 2004 Frequency of CHEK2 mutations in a population-based case-control study of breast cancer in young women Breast Cancer Res 6 629 635 10.1186/bcr933
14. Gameiro CM, Romao F, Castelo-Branco C (2010) Menopause and aging: Changes in the immune system-a review. Maturitas 67(4):316-320
15. Y Gao Y He J Ding K Wu B Hu Y Liu Y Wu B Guo Y Shen D Landi S Landi Y Zhou H Liu 2009 An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma Carcinogenesis 30 2064 2069 19917630 10.1093/carcin/bgp283 1:CAS:528:DC%2BD1MXhsFGhur3K
16. MM Gaudet KM Egan J Lissowska PA Newcomb LA Brinton L Titus-Ernstoff M Yeager S Chanock R Welch B Peplonska A Trentham-Dietz M Garcia-Closas 2007 Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk Hum Genet 121 483 490 17216494 10.1007/s00439-006-0315-x 1:CAS:528:DC%2BD2sXjvVOgtbo%3D (Pubitemid 46554685)
17. MM Gaudet RL Milne A Cox NJ Camp EL Goode MK Humphreys AM Dunning J Morrison GG Giles G Severi L Baglietto DR English FJ Couch JE Olson X Wang J Chang-Claude D Flesch-Janys S Abbas R Salazar A Mannermaa V Kataja VM Kosma A Lindblom S Margolin T Heikkinen K Kampjarvi K Aaltonen H Nevanlinna N Bogdanova I Coinac P Schurmann T Dork CR Bartram RK Schmutzler S Tchatchou B Burwinkel H Brauch D Torres U Hamann C Justenhoven G Ribas JI Arias J Benitez SE Bojesen BG Nordestgaard HL Flyger J Peto O Fletcher N Johnson I dos SS PA Fasching MW Beckmann R Strick AB Ekici A Broeks MK Schmidt FE van Leeuwen LJ van't Veer MC Southey JL Hopper C Apicella CA Haiman BE Henderson ML Le LN Kolonel V Kristensen AG Grenaker DJ Hunter P Kraft DG Cox SE Hankinson C Seynaeve MP Vreeswijk RA Tollenaar P Devilee S Chanock J Lissowska L Brinton B Peplonska K Czene P Hall Y Li J Liu S Balasubramanian S Rafii MW Reed KA Pooley D Conroy C Baynes D Kang KY Yoo DY Noh SH Ahn CY Shen HC Wang JC Yu PE Wu H Anton-Culver A Ziogoas K Egan P Newcomb L Titus-Ernstoff DA Trentham AJ Sigurdson BH Alexander P Bhatti K Allen-Brady LA Cannon-Albright J Wong G Chenevix-Trench AB Spurdle J Beesley PD Pharoah DF Easton M Garcia-Closas 2009 Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium Cancer Epidemiol Biomarkers Prev 18 1610 1616 19423537 10.1158/1055-9965.EPI-08-0745 1:CAS:528:DC%2BD1MXlsFCltLc%3D
18. SI Grivennikov FR Greten M Karin 2010 Immunity, inflammation, and cancer Cell 140 883 899 20303878 10.1016/j.cell.2010.01.025 1:CAS:528: DC%2BC3cXlsVSgu7g%3D
19. BF Hankey LA Ries BK Edwards 1999 The surveillance, epidemiology, and end results program: a national resource Cancer Epidemiol Biomarkers Prev 8 1117 1121 10613347 1:STN:280:DC%2BD3c%2FnvVGjug%3D%3D (Pubitemid 30004912)
20. RE Harris J Beebe-Donk H Doss DD Burr 2005 Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review) Oncol Rep 13 559 583 15756426 1:CAS:528:DC%2BD2MXjtFans74%3D
21. LA Hefler C Grimm T Lantzsch D Lampe S Leodolter H Koelbl G Heinze A Reinthaller D Tong-Cacsire C Tempfer R Zeillinger 2005 Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in Caucasian women Clin Cancer Res 11 5718 5721 16115908 10.1158/1078-0432.CCR-05-0001 1:CAS:528:DC%2BD2MXos1Cjsb4%3D (Pubitemid 41170295)
22. B Iacopetta F Grieu D Joseph 2004 The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype Br J Cancer 90 419 422 14735187 10.1038/sj.bjc.6601545 1:CAS:528: DC%2BD2cXksl2ksg%3D%3D (Pubitemid 38250639)
23. CI Li KE Malone PL Porter NS Weiss MT Tang JR Daling 2003 Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age Int J Cancer 107 647 651 14520705 10.1002/ijc.11465 1:CAS:528:DC%2BD3sXoslCjs74%3D (Pubitemid 37296128)
24. CI Li KE Malone PL Porter NS Weiss MT Tang JR Daling 2003 The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age Cancer Epidemiol Biomarkers Prev 12 1061 1066 14578143 1:CAS:528:DC%2BD3sXosVCru7Y%3D (Pubitemid 37310263)
25. KE Malone JR Daling DR Doody L Hsu L Bernstein RJ Coates PA Marchbanks MS Simon JA McDonald SA Norman BL Strom RT Burkman G Ursin D Deapen LK Weiss S Folger JJ Madeoy DM Friedrichsen NM Suter MC Humphrey R Spirtas EA Ostrander 2006 Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in White and Black American women ages 35 to 64 years Cancer Res 66 8297 8308 16912212 10.1158/0008-5472.CAN-06-0503 1:CAS:528:DC%2BD28XotFWqu74%3D (Pubitemid 44299201)
26. A Mantovani 2010 Molecular pathways linking inflammation and cancer Curr Mol Med 10 369 373 20455855 10.2174/156652410791316968 1:CAS:528: DC%2BC3cXmsVamsb4%3D
27. PA Marchbanks JA McDonald HG Wilson NM Burnett JR Daling L Bernstein KE Malone BL Strom SA Norman LK Weiss JM Liff PA Wingo RT Burkman SG Folger JA Berlin DM Deapen G Ursin RJ Coates MS Simon MF Press R Spirtas 2002 The NICHD women's contraceptive and reproductive experiences study: methods and operational results Ann Epidemiol 12 213 221 11988408 10.1016/S1047-2797(01) 00274-5 (Pubitemid 34414934)
28. H Matsukura S Ikeda N Yoshimura M Takazoe M Muramatsu 2008 Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn's disease Aliment Pharmacol Ther 27 765 770 18248655 10.1111/j.1365-2036.2008.03630.x 1:CAS:528:DC%2BD1cXlvVGqu70%3D (Pubitemid 351490066)
29. SF Moss MJ Blaser 2005 Mechanisms of disease: inflammation and the origins of cancer Nat Clin Pract Oncol 2 90 97 16264881 10.1038/ncponc0081 1:CAS:528:DC%2BD2MXksFGgurk%3D (Pubitemid 40790142)
30. J Pfeilschifter R Koditz M Pfohl H Schatz 2002 Changes in proinflammatory cytokine activity after menopause Endocr Rev 23 90 119 11844745 10.1210/er.23.1.90 1:CAS:528:DC%2BD38XitFOqu7c%3D (Pubitemid 34185307)
31. A Purohit SP Newman MJ Reed 2002 The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer Breast Cancer Res 4 65 69 11879566 10.1186/bcr425 1:CAS:528:DC%2BD38XitlOltbo%3D (Pubitemid 34248122)
32. L Qi RM van Dam JB Meigs JE Manson D Hunter FB Hu 2006 Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis Hum Mol Genet 15 1914 1920 16644865 10.1093/hmg/ddl113 1:CAS:528:DC%2BD28Xksl2gsr8%3D (Pubitemid 43821781)
33. F Rodier JP Coppe CK Patil WA Hoeijmakers DP Munoz SR Raza A Freund E Campeau AR Davalos J Campisi 2009 Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion Nat Cell Biol 11 973 979 19597488 10.1038/ncb1909 1:CAS:528:DC%2BD1MXpsVaktb0%3D
34. L Scola M Vaglica A Crivello L Palmeri GI Forte MC Macaluso A Giacalone NL Di A Bongiovanni C Raimondi A Accardo R Verna G Candore C Caruso D Lio S Palmeri 2006 Cytokine gene polymorphisms and breast cancer susceptibility Ann N Y Acad Sci 1089 104 109 17261759 10.1196/annals.1386.017 1:CAS:528: DC%2BD2sXhsFertL8%3D (Pubitemid 47092072)
35. C Shen H Sun D Sun L Xu X Zhang A Liu X Jia J Bai F Chen Y Yu Y Jin J Yu S Fu 2010 Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis Breast Cancer Res Treat 126 763 770 20882404 10.1007/s10549-010- 1184-5
36. KC Smith AC Bateman HM Fussell WM Howell 2004 Cytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur J Immunogenet 31 167 173 15265021 10.1111/j.1365-2370.2004.00462.x 1:CAS:528:DC%2BD2cXnsFSjsr8%3D (Pubitemid 39049861)
37. BD Smith GL Smith A Hurria GN Hortobagyi TA Buchholz 2009 Future of cancer incidence in the United States: burdens upon an aging, changing nation J Clin Oncol 27 2758 2765 19403886 10.1200/JCO.2008.20.8983
38. NM Suter KE Malone JR Daling DR Doody EA Ostrander 2003 Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women Cancer Epidemiol Biomarkers Prev 12 127 135 12582022 1:CAS:528:DC%2BD3sXhtVOlu7Y%3D (Pubitemid 36194002)
39. B Trabert KE Malone JR Daling DR Doody L Bernstein G Ursin PA Marchbanks BL Strom MC Humphrey EA Ostrander 2007 Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women Breast Cancer Res 9 R84 18067661 10.1186/bcr1833
40. S Volpato JM Guralnik L Ferrucci J Balfour P Chaves LP Fried TB Harris 2001 Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study Circulation 103 947 953 11181468 1:CAS:528:DC%2BD3MXit1Cqsr4%3D (Pubitemid 32183799)